UniProt ID | ERLN1_HUMAN | |
---|---|---|
UniProt AC | O75477 | |
Protein Name | Erlin-1 | |
Gene Name | ERLIN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 346 | |
Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein . Associated with lipid raft-like domains of the endoplasmic reticulum membrane. |
|
Protein Description | Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. Binds cholesterol and may promote ER retention of the SCAP-SREBF complex. [PubMed: 24217618] | |
Protein Sequence | MTQARVLVAAVVGLVAVLLYASIHKIEEGHLAVYYRGGALLTSPSGPGYHIMLPFITTFRSVQTTLQTDEVKNVPCGTSGGVMIYIDRIEVVNMLAPYAVFDIVRNYTADYDKTLIFNKIHHELNQFCSAHTLQEVYIELFDQIDENLKQALQKDLNLMAPGLTIQAVRVTKPKIPEAIRRNFELMEAEKTKLLIAAQKQKVVEKEAETERKKAVIEAEKIAQVAKIRFQQKVMEKETEKRISEIEDAAFLAREKAKADAEYYAAHKYATSNKHKLTPEYLELKKYQAIASNSKIYFGSNIPNMFVDSSCALKYSDIRTGRESSLPSKEALEPSGENVIQNKESTG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTQARVLVA ------CCHHHHHHH | 30.82 | - | |
20 | Phosphorylation | GLVAVLLYASIHKIE HHHHHHHHHHHHHHH | 8.30 | 30576142 | |
22 | Phosphorylation | VAVLLYASIHKIEEG HHHHHHHHHHHHHHC | 16.21 | 30576142 | |
42 | Phosphorylation | YRGGALLTSPSGPGY EECCEEEECCCCCCE | 39.17 | 24719451 | |
43 | Phosphorylation | RGGALLTSPSGPGYH ECCEEEECCCCCCEE | 19.62 | 24719451 | |
49 | Phosphorylation | TSPSGPGYHIMLPFI ECCCCCCEEEEEEEH | 7.42 | 24719451 | |
58 | Phosphorylation | IMLPFITTFRSVQTT EEEEEHHCCCCCCCC | 16.54 | 28857561 | |
61 | Phosphorylation | PFITTFRSVQTTLQT EEHHCCCCCCCCCCC | 17.87 | 28857561 | |
63 | Phosphorylation | ITTFRSVQTTLQTDE HHCCCCCCCCCCCCC | 29.98 | - | |
64 | Phosphorylation | TTFRSVQTTLQTDEV HCCCCCCCCCCCCCC | 27.58 | 28857561 | |
65 | Phosphorylation | TFRSVQTTLQTDEVK CCCCCCCCCCCCCCC | 10.36 | 28857561 | |
68 | Phosphorylation | SVQTTLQTDEVKNVP CCCCCCCCCCCCCCC | 36.92 | 28857561 | |
106 | N-linked_Glycosylation | AVFDIVRNYTADYDK HHHHHHHHCCCCCCC | 27.84 | 19159218 | |
107 | Phosphorylation | VFDIVRNYTADYDKT HHHHHHHCCCCCCCE | 7.85 | 29083192 | |
108 | Phosphorylation | FDIVRNYTADYDKTL HHHHHHCCCCCCCEE | 19.32 | 29083192 | |
108 | N-linked_Glycosylation | FDIVRNYTADYDKTL HHHHHHCCCCCCCEE | 19.32 | 20068230 | |
108 | N-linked_Glycosylation | FDIVRNYTADYDKTL HHHHHHCCCCCCCEE | 19.32 | 20068230 | |
111 | Phosphorylation | VRNYTADYDKTLIFN HHHCCCCCCCEEHHH | 19.51 | 29083192 | |
113 | Ubiquitination | NYTADYDKTLIFNKI HCCCCCCCEEHHHHH | 38.71 | - | |
115 | Ubiquitination | TADYDKTLIFNKIHH CCCCCCEEHHHHHHH | 5.32 | 22817900 | |
151 | Ubiquitination | IDENLKQALQKDLNL HCHHHHHHHHHHHCC | 15.46 | 22817900 | |
154 | Ubiquitination | NLKQALQKDLNLMAP HHHHHHHHHHCCCCC | 66.10 | 21890473 | |
156 | Ubiquitination | KQALQKDLNLMAPGL HHHHHHHHCCCCCCE | 7.36 | 21906983 | |
156 | Ubiquitination | KQALQKDLNLMAPGL HHHHHHHHCCCCCCE | 7.36 | 21890473 | |
176 | Ubiquitination | RVTKPKIPEAIRRNF EECCCCCHHHHHHCH | 30.96 | 24816145 | |
190 | Ubiquitination | FELMEAEKTKLLIAA HHHHHHHHHHHHHHH | 58.99 | - | |
191 | Phosphorylation | ELMEAEKTKLLIAAQ HHHHHHHHHHHHHHH | 20.59 | 25599653 | |
192 | 2-Hydroxyisobutyrylation | LMEAEKTKLLIAAQK HHHHHHHHHHHHHHH | 52.98 | - | |
192 | Ubiquitination | LMEAEKTKLLIAAQK HHHHHHHHHHHHHHH | 52.98 | 22817900 | |
194 | Ubiquitination | EAEKTKLLIAAQKQK HHHHHHHHHHHHHHH | 2.39 | 22817900 | |
199 | Ubiquitination | KLLIAAQKQKVVEKE HHHHHHHHHHHHHHH | 47.57 | - | |
201 | 2-Hydroxyisobutyrylation | LIAAQKQKVVEKEAE HHHHHHHHHHHHHHH | 56.11 | - | |
201 | Ubiquitination | LIAAQKQKVVEKEAE HHHHHHHHHHHHHHH | 56.11 | 27667366 | |
222 | 2-Hydroxyisobutyrylation | VIEAEKIAQVAKIRF HHHHHHHHHHHHHHH | 14.63 | - | |
226 | Acetylation | EKIAQVAKIRFQQKV HHHHHHHHHHHHHHH | 35.24 | 26051181 | |
226 | Ubiquitination | EKIAQVAKIRFQQKV HHHHHHHHHHHHHHH | 35.24 | - | |
228 | Ubiquitination | IAQVAKIRFQQKVME HHHHHHHHHHHHHHH | 23.71 | - | |
238 | Ubiquitination | QKVMEKETEKRISEI HHHHHHHHHHHHHHH | 58.85 | 24816145 | |
238 | Phosphorylation | QKVMEKETEKRISEI HHHHHHHHHHHHHHH | 58.85 | 25599653 | |
257 | Ubiquitination | FLAREKAKADAEYYA HHHHHHHHHHHHHHH | 58.84 | - | |
259 | Ubiquitination | AREKAKADAEYYAAH HHHHHHHHHHHHHHH | 38.95 | - | |
259 | 2-Hydroxyisobutyrylation | AREKAKADAEYYAAH HHHHHHHHHHHHHHH | 38.95 | - | |
262 | Phosphorylation | KAKADAEYYAAHKYA HHHHHHHHHHHHHHH | 10.50 | 28152594 | |
263 | Phosphorylation | AKADAEYYAAHKYAT HHHHHHHHHHHHHHH | 6.71 | 28152594 | |
264 | Phosphorylation | KADAEYYAAHKYATS HHHHHHHHHHHHHHC | 11.37 | - | |
265 | Phosphorylation | ADAEYYAAHKYATSN HHHHHHHHHHHHHCC | 5.42 | - | |
267 | Ubiquitination | AEYYAAHKYATSNKH HHHHHHHHHHHCCCC | 31.67 | - | |
267 | Acetylation | AEYYAAHKYATSNKH HHHHHHHHHHHCCCC | 31.67 | 19608861 | |
269 | Acetylation | YYAAHKYATSNKHKL HHHHHHHHHCCCCCC | 14.89 | 19608861 | |
269 | Ubiquitination | YYAAHKYATSNKHKL HHHHHHHHHCCCCCC | 14.89 | 19608861 | |
275 | Acetylation | YATSNKHKLTPEYLE HHHCCCCCCCHHHHH | 56.52 | 26051181 | |
275 | Ubiquitination | YATSNKHKLTPEYLE HHHCCCCCCCHHHHH | 56.52 | - | |
277 | Phosphorylation | TSNKHKLTPEYLELK HCCCCCCCHHHHHHH | 20.91 | - | |
280 | Phosphorylation | KHKLTPEYLELKKYQ CCCCCHHHHHHHHHH | 13.48 | 28152594 | |
282 | Phosphorylation | KLTPEYLELKKYQAI CCCHHHHHHHHHHHH | 58.61 | - | |
286 | Ubiquitination | EYLELKKYQAIASNS HHHHHHHHHHHHCCC | 11.11 | 29967540 | |
287 | Ubiquitination | YLELKKYQAIASNSK HHHHHHHHHHHCCCE | 34.86 | - | |
319 | Phosphorylation | LKYSDIRTGRESSLP CCHHHHCCCCCCCCC | 40.71 | 25693802 | |
323 | Phosphorylation | DIRTGRESSLPSKEA HHCCCCCCCCCCHHH | 35.50 | 20068231 | |
324 | Phosphorylation | IRTGRESSLPSKEAL HCCCCCCCCCCHHHC | 39.28 | 23401153 | |
326 | Phosphorylation | TGRESSLPSKEALEP CCCCCCCCCHHHCCC | 45.35 | 20068231 | |
327 | Phosphorylation | GRESSLPSKEALEPS CCCCCCCCHHHCCCC | 48.71 | 20068231 | |
328 | Ubiquitination | RESSLPSKEALEPSG CCCCCCCHHHCCCCC | 45.10 | - | |
329 | Phosphorylation | ESSLPSKEALEPSGE CCCCCCHHHCCCCCC | 63.93 | 20068231 | |
330 | Ubiquitination | SSLPSKEALEPSGEN CCCCCHHHCCCCCCC | 22.44 | 22817900 | |
334 | Phosphorylation | SKEALEPSGENVIQN CHHHCCCCCCCCCCC | 49.73 | 25159151 | |
336 | Phosphorylation | EALEPSGENVIQNKE HHCCCCCCCCCCCCC | 53.30 | - | |
342 | Ubiquitination | GENVIQNKESTG--- CCCCCCCCCCCC--- | 36.34 | - | |
344 | Phosphorylation | NVIQNKESTG----- CCCCCCCCCC----- | 39.79 | 25627689 | |
344 | Ubiquitination | NVIQNKESTG----- CCCCCCCCCC----- | 39.79 | - | |
345 | Phosphorylation | VIQNKESTG------ CCCCCCCCC------ | 48.26 | 25627689 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERLN1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERLN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERLN1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ERLN2_HUMAN | ERLIN2 | physical | 19240031 | |
AMFR_HUMAN | AMFR | physical | 21343306 | |
RN139_HUMAN | RNF139 | physical | 21343306 | |
SYVN1_HUMAN | SYVN1 | physical | 21343306 | |
ERLN2_HUMAN | ERLIN2 | physical | 22939629 | |
NDUAC_HUMAN | NDUFA12 | physical | 22939629 | |
SSRG_HUMAN | SSR3 | physical | 22939629 | |
RALY_HUMAN | RALY | physical | 22939629 | |
ERLN2_HUMAN | ERLIN2 | physical | 24217618 | |
INSI1_HUMAN | INSIG1 | physical | 24217618 | |
SCAP_CRIGR | Scap | physical | 24217618 | |
SC22A_HUMAN | SEC22A | physical | 25416956 | |
FA2H_HUMAN | FA2H | physical | 25416956 | |
TM199_HUMAN | TMEM199 | physical | 25416956 | |
AGR3_HUMAN | AGR3 | physical | 25416956 | |
DUS3_HUMAN | DUSP3 | physical | 28514442 | |
CF120_HUMAN | C6orf120 | physical | 28514442 | |
STOM_HUMAN | STOM | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-267, AND MASS SPECTROMETRY. | |
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-106, AND MASSSPECTROMETRY. |